Reports

Global Periodic Fever Syndrome Market to Grow at a Steady Pace During 2021-2026, Aided by the Growing Research and Development Activities

Periodic Fever Syndrome Market

Global Periodic Fever Syndrome Market: By Treatment: Oral Anti-Inflammatory Drugs, Non-Steroidal Anti-Inflammatory Drugs, Others; By Indication; By Route of Administration; By Distribution Channel; By End Use; Regional Analysis; Historical Market and Forecast (2018-2028); Competitive Landscape; Industry Events and Developments

Global Periodic Fever Syndrome Market Outlook

The global periodic fever syndrome market is expected to witness a steady growth in the forecast period of 2023-2028.

 

Periodic Fever Syndrome Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

North America to Significantly Contribute to the Periodic Fever Syndrome Industry Growth

North America is one of the leading regions in the global periodic fever syndrome industry. The region accounts for a significant share of the total market value owing to the growing penetration of the major players in the region and the greater focus on patient care and monitoring. The growing investments in the research and development activities, coupled with the availability of advanced healthcare infrastructure in the region, are aiding the industry growth in North America. However, there still remains the difficulty in the diagnosis of periodic fever syndrome due to unrelated symptoms, which is a key challenge faced by the market players.

 

Periodic Fever Syndrome Market by End Use

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Periodic Fever Syndrome: Market Segmentation

Periodic fever syndromes are a group of rare autoinflammatory diseases in which a patient experiences recurrent episodes of fever over time, usually accompanied by similar symptoms. The disease causes periodic (episodic) fever, often accompanied by rashes and joint pain, that do not have an infectious (virus, bacteria) cause, and each episode of fever usually lasts roughly the same length of time. These disorders are genetic conditions and are very rare. Among children, periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) is the most common type of periodic fever syndrome. These disorders are milder and less obvious in adults than in children.

On the basis of treatment, the market is divided into:

  • Oral Anti-Inflammatory Drugs
  • Non-Steroidal Anti-Inflammatory Drugs
  • Anti-TNF Therapy
  • Statins
  • Others

By indication, the industry can be segmented into:

  • Hyperimmunoglobulinemia D Syndrome 
  • Familial Mediterranean Fever 
  • TNF Receptor-Associated Periodic Syndrome 
  • Cryopyrin-Associated Periodic Syndrome
  • Others

The various routes of administration are:

  • Oral
  • Injections
  • Others

The major distribution channels in the industry include:

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online
  • Others

Based on end use sector, the industry can be categorised into:

  • Hospitals
  • Speciality Centres
  • Others

The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Periodic Fever Syndrome Market by Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Rising Health Awareness and New Drug Approvals by the Government Bodies to Augment the Global Market for Periodic Fever Syndrome

There is limited knowledge and limited treatment options available for periodic fever syndrome. The growing government initiatives to raise public awareness regarding such rare disorders are aiding the industry growth. Currently, the treatment of periodic fever syndrome is carried out using oral anti-inflammatory drugs, such as corticosteroids, and non-steroidal anti-inflammatory drugs (NSAIDs), among others, which helps to control the symptoms associated with the disease but does not assist in its elimination. However, the rapid technological advancements and the growing research activities are leading to the development of improved diagnostic facilities and new drugs and therapies. The new drug approvals for the treatment of this rare disorder is expected to have a positive effect on the expansion of the periodic fever syndrome industry. In developed nations, the growing government investments in the development of healthcare infrastructure will further boost the market expansion over the forecast period.

 

Key Industry Players in the Global Periodic Fever Syndrome Market

The report gives a detailed analysis of the following key players in the global periodic fever syndrome market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Swedish Orphan Biovitrum AB
  • Novartis AG
  • Texas Allergy Group, PLLC
  • Others

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

 

REPORT FEATURES DETAILS
Base Year 2022
Historical Period 2018-2022
Forecast Period 2023-2028
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Treatment, Indication, Route of Administration, Distribution Channel, End Use, Region
Breakup by Treatment Oral Anti-Inflammatory Drugs, Non-Steroidal Anti-Inflammatory Drugs, Anti-TNF Therapy, Statins, Others
Breakup by Indication Hyperimmunoglobulinemia D Syndrome, Familial Mediterranean Fever, TNF Receptor-Associated Periodic Syndrome, Cryopyrin-Associated Periodic Syndrome, Others
Breakup by Route of Administration Oral, Injections, Others
Breakup by Distribution Channel Hospital Pharmacy, Retail Pharmacy, Online, Others
Breakup by End Use Hospitals, Speciality Centres, Others
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered Swedish Orphan Biovitrum AB, Novartis AG, Texas Allergy Group, PLLC, Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description
    3.1    Market Definition and Outlook
    3.2    Properties and End Uses
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary
    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Opportunities and Challenges in the Market
8    Global Periodic Fever Syndrome Market Analysis
    8.1    Key Industry Highlights
    8.2    Global Periodic Fever Syndrome Historical Market (2018-2022) 
    8.3    Global Periodic Fever Syndrome Market Forecast (2023-2028)
    8.4    Global Periodic Fever Syndrome Market by Treatment
        8.4.1    Oral Anti-Inflammatory Drugs
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2018-2022)
            8.4.1.3    Forecast Trend (2023-2028)
        8.4.2    Non-Steroidal Anti-Inflammatory Drugs
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2018-2022)
            8.4.2.3    Forecast Trend (2023-2028)
        8.4.3    Anti-TNF Therapy
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2018-2022)
            8.4.3.3    Forecast Trend (2023-2028)
        8.4.4    Statins
            8.4.4.1    Market Share
            8.4.4.2    Historical Trend (2018-2022)
            8.4.4.3    Forecast Trend (2023-2028)
        8.4.5    Others
    8.5    Global Periodic Fever Syndrome Market by Indication
        8.5.1    Hyperimmunoglobulinemia D Syndrome
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2018-2022)
            8.5.1.3    Forecast Trend (2023-2028)
        8.5.2    Familial Mediterranean Fever
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2018-2022)
            8.5.2.3    Forecast Trend (2023-2028)
        8.5.3    TNF Receptor-Associated Periodic Syndrome
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2018-2022)
            8.5.3.3    Forecast Trend (2023-2028)
        8.5.4    Cryopyrin-Associated Periodic Syndrome
            8.5.4.1    Market Share
            8.5.4.2    Historical Trend (2018-2022)
            8.5.4.3    Forecast Trend (2023-2028)
        8.5.5    Others
    8.6    Global Periodic Fever Syndrome Market by Route of Administration
        8.6.1    Oral
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2018-2022)
            8.6.1.3    Forecast Trend (2023-2028)
        8.6.2    Injections
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2018-2022)
            8.6.2.3    Forecast Trend (2023-2028)
        8.6.3    Others
    8.7    Global Periodic Fever Syndrome Market by Distribution Channel
        8.7.1    Hospital Pharmacy
            8.7.1.1    Market Share
            8.7.1.2    Historical Trend (2018-2022)
            8.7.1.3    Forecast Trend (2023-2028)
        8.7.2    Retail Pharmacy
            8.7.2.1    Market Share
            8.7.2.2    Historical Trend (2018-2022)
            8.7.2.3    Forecast Trend (2023-2028)
        8.7.3    Online
            8.7.3.1    Market Share
            8.7.3.2    Historical Trend (2018-2022)
            8.7.3.3    Forecast Trend (2023-2028)
        8.7.4    Others
    8.8    Global Periodic Fever Syndrome Market by End Use
        8.8.1    Hospitals
            8.8.1.1    Market Share
            8.8.1.2    Historical Trend (2018-2022)
            8.8.1.3    Forecast Trend (2023-2028)
        8.8.2    Speciality Centres
            8.8.2.1    Market Share
            8.8.2.2    Historical Trend (2018-2022)
            8.8.2.3    Forecast Trend (2023-2028)
        8.8.3    Others    
    8.9    Global Periodic Fever Syndrome Market by Region
        8.9.1    North America
            8.9.1.1    Market Share
            8.9.1.2    Historical Trend (2017-2021) 
            8.9.1.3    Forecast Trend (2022-2027)
        8.9.2    Europe
            8.9.2.1    Market Share
            8.9.2.2    Historical Trend (2017-2021) 
            8.9.2.3    Forecast Trend (2022-2027)
        8.9.3    Asia Pacific
            8.9.3.1    Market Share
            8.9.3.2    Historical Trend (2017-2021) 
            8.9.3.3    Forecast Trend (2022-2027)
        8.9.4    Latin America
            8.9.4.1    Market Share
            8.9.4.2    Historical Trend (2017-2021) 
            8.9.4.3    Forecast Trend (2022-2027)
        8.9.5    Middle East and Africa
            8.9.5.1    Market Share
            8.9.5.2    Historical Trend (2017-2021) 
            8.9.5.3    Forecast Trend (2022-2027)
9    North America Periodic Fever Syndrome Market Analysis
    9.1    United States of America 
        9.1.1    Market Share
        9.1.2    Historical Trend (2017-2021) 
        9.1.3    Forecast Trend (2022-2027)
    9.2    Canada
        9.2.1    Market Share
        9.2.2    Historical Trend (2017-2021) 
        9.2.3    Forecast Trend (2022-2027)
10    Europe Periodic Fever Syndrome Market Analysis
    10.1    United Kingdom
        10.1.1    Market Share
        10.1.2    Historical Trend (2017-2021) 
        10.1.3    Forecast Trend (2022-2027)
    10.2    Germany
        10.2.1    Market Share
        10.2.2    Historical Trend (2017-2021) 
        10.2.3    Forecast Trend (2022-2027)
    10.3    France
        10.3.1    Market Share
        10.3.2    Historical Trend (2017-2021) 
        10.3.3    Forecast Trend (2022-2027)
    10.4    Italy
        10.4.1    Market Share
        10.4.2    Historical Trend (2017-2021) 
        10.4.3    Forecast Trend (2022-2027)
    10.5    Others
11    Asia Pacific Periodic Fever Syndrome Market Analysis
    11.1    China
        11.1.1    Market Share
        11.1.2    Historical Trend (2017-2021) 
        11.1.3    Forecast Trend (2022-2027)
    11.2    Japan
        11.2.1    Market Share
        11.2.2    Historical Trend (2017-2021) 
        11.2.3    Forecast Trend (2022-2027)
    11.3    India
        11.3.1    Market Share
        11.3.2    Historical Trend (2017-2021) 
        11.3.3    Forecast Trend (2022-2027)
    11.4    ASEAN
        11.4.1    Market Share
        11.4.2    Historical Trend (2017-2021) 
        11.4.3    Forecast Trend (2022-2027)
    11.5    Australia
        11.5.1    Market Share
        11.5.2    Historical Trend (2017-2021) 
        11.5.3    Forecast Trend (2022-2027)
    11.6    Others
12    Latin America Periodic Fever  Syndrome Market Analysis
    12.1    Brazil
        12.1.1    Market Share
        12.1.2    Historical Trend (2017-2021) 
        12.1.3    Forecast Trend (2022-2027)
    12.2    Argentina
        12.2.1    Market Share
        12.2.2    Historical Trend (2017-2021) 
        12.2.3    Forecast Trend (2022-2027)
    12.3    Mexico
        12.3.1    Market Share
        12.3.2    Historical Trend (2017-2021) 
        12.3.3    Forecast Trend (2022-2027)
    12.4    Others
13    Middle East and Africa Periodic Fever Syndrome Market Analysis
    13.1    Saudi Arabia
        13.1.1    Market Share
        13.1.2    Historical Trend (2017-2021) 
        13.1.3    Forecast Trend (2022-2027)
    13.2    United Arab Emirates
        13.2.1    Market Share
        13.2.2    Historical Trend (2017-2021) 
        13.2.3    Forecast Trend (2022-2027)
    13.3    Nigeria
        13.3.1    Market Share
        13.3.2    Historical Trend (2017-2021) 
        13.3.3    Forecast Trend (2022-2027)
    13.4    South Africa
        13.4.1    Market Share
        13.4.2    Historical Trend (2017-2021) 
        13.4.3    Forecast Trend (2022-2027)
    13.5    Others
14    Market Dynamics
    14.1    SWOT Analysis
        14.1.1    Strengths
        14.1.2    Weaknesses
        14.1.3    Opportunities
        14.1.4    Threats
    14.2    Porter’s Five Forces Analysis
        14.2.1    Supplier’s Power
        14.2.2    Buyer’s Power
        14.2.3    Threat of New Entrants
        14.2.4    Degree of Rivalry
        14.2.5    Threat of Substitutes
    14.3    Key Indicators for Demand
    14.4    Key Indicators for Price
15    Value Chain  Analysis
16    Competitive Landscape
    16.1    Market Structure
    16.2    Company Profiles
        16.2.1    Swedish Orphan Biovitrum AB
            16.2.1.1    Company Overview
            16.2.1.2    Product Portfolio
            16.2.1.3    Demographic Reach and Achievements
            16.2.1.4    Certifications
        16.2.2    Novartis AG
            16.2.2.1    Company Overview
            16.2.2.2    Product Portfolio
            16.2.2.3    Demographic Reach and Achievements
            16.2.2.4    Certifications
        16.2.3    Texas Allergy Group, PLLC
            16.2.3.1    Company Overview
            16.2.3.2    Product Portfolio
            16.2.3.3    Demographic Reach and Achievements
            16.2.3.4    Certifications
        16.2.4    Others
17    Key Trends and Developments in the Market


List of Key Figures and Tables

1.    Global Periodic Fever Syndrome Market: Key Industry Highlights, 2018 and 2028
2.    Global Periodic Fever Syndrome Historical Market: Breakup by Treatment (USD Billion), 2018-2022
3.    Global Periodic Fever Syndrome Market Forecast: Breakup by Treatment (USD Billion), 2023-2028
4.    Global Periodic Fever Syndrome Historical Market: Breakup by Indication (USD Billion), 2018-2022
5.    Global Periodic Fever Syndrome Market Forecast: Breakup by Indication (USD Billion), 2023-2028
6.    Global Periodic Fever Syndrome Historical Market: Breakup by Route of Administration (USD Billion), 2018-2022
7.    Global Periodic Fever Syndrome Market Forecast: Breakup by Route of Administration (USD Billion), 2023-2028
8.    Global Periodic Fever Syndrome Historical Market: Breakup by Distribution Channel (USD Billion), 2018-2022
9.    Global Periodic Fever Syndrome Market Forecast: Breakup by Distribution Channel (USD Billion), 2023-2028
10.    Global Periodic Fever Syndrome Historical Market: Breakup by End Use (USD Billion), 2018-2022
11.    Global Periodic Fever Syndrome Market Forecast: Breakup by End Use (USD Billion), 2023-2028
12.    Global Periodic Fever Syndrome Historical Market: Breakup by Region (USD Billion), 2018-2022
13.    Global Periodic Fever Syndrome Market Forecast: Breakup by Region (USD Billion), 2023-2028
14.    North America Periodic Fever Syndrome Historical Market: Breakup by Country (USD Billion), 2018-2022
15.    North America Periodic Fever Syndrome Market Forecast: Breakup by Country (USD Billion), 2023-2028
16.    Europe Periodic Fever Syndrome Historical Market: Breakup by Country (USD Billion), 2018-2022
17.    Europe Periodic Fever Syndrome Market Forecast: Breakup by Country (USD Billion), 2023-2028
18.    Asia Pacific Periodic Fever Syndrome Historical Market: Breakup by Country (USD Billion), 2018-2022
19.    Asia Pacific Periodic Fever Syndrome Market Forecast: Breakup by Country (USD Billion), 2023-2028
20.    Latin America Periodic Fever Syndrome Historical Market: Breakup by Country (USD Billion), 2018-2022
21.    Latin America Periodic Fever Syndrome Market Forecast: Breakup by Country (USD Billion), 2023-2028
22.    Middle East and Africa Periodic Fever Syndrome Historical Market: Breakup by Country (USD Billion), 2018-2022
23.    Middle East and Africa Periodic Fever Syndrome Market Forecast: Breakup by Country (USD Billion), 2023-2028
24.    Global Periodic Fever Syndrome Market Structure

Key Questions Answered in the Report

What is the forecast outlook of the global periodic fever syndrome market for 2023-2028?

The global periodic fever syndrome market is estimated to witness a steady growth in the forecast period of 2023-2028.

What are the major industry drivers?

The major drivers of the industry, such as rising disposable incomes, increasing population, rising focus on patient care and monitoring, increasing government initiatives to raise public awareness regarding such rare disorders, growing technological advancements, rising research activities, and new drug approvals for the treatment, are expected to aid the market growth.

What are the key industry trends of the global periodic fever syndrome market?

The key trends guiding the growth of the market include the rising investments in the research and development activities and the increasing availability of advanced healthcare infrastructure.

What are the major regional markets of periodic fever syndrome, according to the EMR report?

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

What are the leading treatments of periodic fever syndrome in the market?

The leading treatments of periodic fever syndrome in the market are oral anti-inflammatory drugs, non-steroidal anti-inflammatory drugs, anti-TNF therapy, and statins, among others.

What are the major indications of periodic fever syndrome in the industry?

The major indications of periodic fever syndrome in the industry are hyperimmunoglobulinemia D syndrome, familial mediterranean fever, TNF receptor-associated periodic syndrome, and cryopyrin-associated periodic syndrome, among others.

What are the significant routes of administration in the market?

The significant routes of administration in the market are oral and injections, among others.

What are the major distribution channels in the industry?

The major distribution channels in the industry are hospital pharmacy, retail pharmacy, and online, among others.

What are the leading end-use sectors in the market?

The leading end-use sectors in the market are hospitals and speciality centres, among others.

Who are the key industry players, according to the report?

The major players in the industry are Swedish Orphan Biovitrum AB, Novartis AG, and Texas Allergy Group, PLLC, among others.

Analyst Review

The global periodic fever syndrome market is being driven by the rising advancements in the healthcare sector. Aided by the rising R&D activities, the market is expected to witness a steady growth in the forecast period of 2023-2028.

EMR's meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on treatment, the market is segmented into oral anti-inflammatory drugs, non-steroidal anti-inflammatory drugs, anti-TNF therapy, and statins, among others. On the basis of indication, the market is divided into hyperimmunoglobulinemia D syndrome, familial mediterranean fever, TNF receptor-associated periodic syndrome, and cryopyrin-associated periodic syndrome, among others. By route of administration, the industry is segmented into oral and injections, among others. The leading distribution channels in the market are hospital pharmacy, retail pharmacy, and online, among others. Based on end use, the industry is divided into hospitals and speciality centres, among others. The major regional markets for periodic fever syndrome are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Swedish Orphan Biovitrum AB, Novartis AG, and Texas Allergy Group, PLLC, among others.

EMR's research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1699
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
Buy Now

Single User License

$2799
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
Buy Now
most popular

Five User License

$3999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
Buy Now

Corporate License

$4999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
Buy Now

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER